Shield Therapeutics plc (AIM:STX)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 122.11M |
| Revenue (ttm) | 30.29M |
| Net Income (ttm) | -15.50M |
| Shares Out | 1.06B |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,300,709 |
| Average Volume | 4,629,518 |
| Open | 11.38 |
| Previous Close | 11.30 |
| Day's Range | 10.95 - 11.80 |
| 52-Week Range | 2.10 - 12.50 |
| Beta | 1.76 |
| RSI | 78.32 |
| Earnings Date | Sep 5, 2025 |
About Shield Therapeutics
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom. [Read more]
Financial Performance
In 2024, Shield Therapeutics's revenue was $32.18 million, an increase of 145.93% compared to the previous year's $13.09 million. Losses were -$27.18 million, -18.36% less than in 2023.
Financial numbers in USD Financial StatementsNews
Shield Therapeutics plc (SHIEF) Q3 2025 Sales/ Trading Statement Call - Slideshow
2025-10-29. The following slide deck was published by Shield Therapeutics plc in conjunction with this event.
UK Stock Market News: GSK, DCC, Shield Therapeutics
Sales up at GSK but profits hit by Zantac settlement, Q3 profits up at DCC, Shield eyes positive cashflow by year end amidst surge in sales
Small Cap Stocks: Microsalt, Proton Motor Power, Eckoh
Microsalt, Proton Motor Power, Eckoh, CAP-XX and Shield Therapeutics are today's biggest Small Cap risers and fallers at the market close
Small Cap Stocks: Seascape Energy, Arkle, Mirriad
Seascape Energy, Arkle, Pennant International, Mirriad, Shield Therapeutics are today's biggest Small Cap stock movers
OTC Markets Group Welcomes Shield Therapeutics PLC to OTCQX
NEW YORK, May 17, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Shield Therapeutics PLC (LSE: STXS; OT...